CD44 and cancer: In order to increase the binding affinity selectively for the surface of cancer cells, the nanoparticles were non-covalently conjugated to hyaluronic acid (HA), a natural biopolymer, which was found to mediate the targeting recognition of CD44 over-expressing cancer cells.